Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

ClinicalTrials.gov public records Last synced May 22, 2026, 5:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–28 of 4 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Rubella Clear all

Completed Phase 2 Interventional Accepts healthy volunteers Results available

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

NCT05630846

View directory record Official record

Conditions: Measles; Mumps; Rubella; Chickenpox, Measles
Interventions: Investigational MMRV(H)NS vaccine, Investigational MM(H)RVNS vaccine, Investigational M(L)M(L)R(L)V(L)NS vaccine, Marketed MMRV_Lot 1 and Lot 2 vaccine; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 4 Years to 6 Years

Enrollment: 801 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 35
States / cities: Birmingham, Alabama • Jonesboro, Arkansas • Bellflower, California + 30 more

Source: ClinicalTrials.gov public record

Updated Jun 21, 2025 · Synced May 22, 2026, 5:57 AM EDT

Completed Not applicable Interventional

Examining Adolescent Assessment, Feedback, Incentive, and Exchange (AFIX) in North Carolina

NCT01544764

View directory record Official record

Conditions: Adolescent Health Services, Immunization
Interventions: Assessment , Feedback, Incentives, and eXchange Program; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: Not listed

Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Raleigh, North Carolina

Source: ClinicalTrials.gov public record

Updated Dec 17, 2013 · Synced May 22, 2026, 5:57 AM EDT

Completed Phase 2 Interventional Accepts healthy volunteers

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

NCT00000815

View directory record Official record

Conditions: HIV Infections, Measles
Interventions: Attenuvax, M-M-R-II; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 6 Months to 7 Months

Enrollment: 270 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Ends 2001
U.S. locations: 43
States / cities: Birmingham, Alabama • Long Beach, California • Los Angeles, California + 29 more

Source: ClinicalTrials.gov public record

Updated Oct 27, 2021 · Synced May 22, 2026, 5:57 AM EDT

Completed Phase 3 Interventional Accepts healthy volunteers Results available

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

NCT02058563

View directory record Official record

Conditions: Rubella, Mumps, Measles
Interventions: Priorix®, Merck's M-M-R®II, Measles, Mumps, and Rubella Virus Vaccine; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 7 Years and older

Enrollment: 996 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 10
States / cities: Birmingham, Alabama • Chandler, Arizona • Mesa, Arizona + 6 more

Source: ClinicalTrials.gov public record

Updated Jun 5, 2018 · Synced May 22, 2026, 5:57 AM EDT